Synaptic inhibition in the vertebrate central nervous system is mediat
ed predominantly by subtypes of the GABA(A) receptor; which comprise d
ifferent pentameric combinations of the products of 13 genes. In this
article, we review the results of recent experiments that are helping
to define binding-site determinants, on GABA(A) receptors, for various
ligands and some clinically-important modulators. New and sometimes c
onflicting data, on the polypeptide compositions of native subtypes, w
ill also be discussed. Studies such as those described here should ult
imately bad to a molecular understanding of receptor-ligand interactio
ns, and the biological basis for the large number of subtypes that app
ear to exist in brain.